Sensitivity and specificity of a syphilis rapid diagnostic test in blood donors' samples
Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER BRAZIL
Autores
ARAI, Carolina
LEMOS-MACHADO, Juliano Alves
AUN, Marcelo Vivolo
BONET-BUB, Carolina
SANTOS, Leandro Dinalli
MIRANDA, Angelica Espinosa
Citação
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, v.27, n.6, article ID 103689, 4p, 2023
Resumo
Rapid Diagnostic Tests (RDT) are useful to identify syphilis cases, particularly for hard-to-reach populations and if laboratory services are scarce. However, RDT performance may be subopti-mal. We aimed to assess the sensitivity and specificity of a syphilis RDT using well-characterized blood donors' samples. We categorized samples from 811 blood donors into five groups: 1 - Sam-ples with reactive Chemiluminescence (QML), FTA-Abs, and VDRL; 2 -Samples with reactive QML and FTA-Abs, and nonreactive VDRL; 3 -Samples with reactive QML, and nonreactive for other markers (false-positives); 4 -Controls with nonreactive QML; and 5 -Samples reactive for HIV, with nonreactive QML. Sensitivity was tested in groups 1 (overall and according to VDRL titers) and 2; specificity was tested in groups 3-5. The RDT had high specificity, even in samples reactive for HIV. The sensitivity was high (91.9%) in samples with reactive VDRL but varied between 75.0%-100% according to VDRL titers. The overall sensitivity was lower (81.3%) in sam-ples with reactive FTA-Abs and nonreactive VDRL. The RDT is a useful tool to detect active syph-ilis but may be more limited for cases with very early or remote infection, or those with prior treatment. When higher sensitivity is needed, additional strategies including recurrent testing or laboratory-based tests may be required.(c) 2023 Sociedade Brasileira de Infectologia.
Palavras-chave
Syphilis, Syphilis serodiagnosis, Sensitivity and speci ficity, Point-of-care testing
Referências
- Bristow CC, 2020, CLIN INFECT DIS, V71, pS52, DOI 10.1093/cid/ciaa350
- Girma S, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0270878
- Kojima N, 2018, CURR EPIDEMIOL REP, V5, P24, DOI 10.1007/s40471-018-0138-z
- Mishra S, 2010, SEX TRANSM INFECT, V86, P193, DOI 10.1136/sti.2009.038778
- Peeling RW, 2010, CLIN MICROBIOL INFEC, V16, P1062, DOI 10.1111/j.1469-0691.2010.03279.x
- Peeling RW, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.73
- ROMPALO AM, 1992, J INFECT DIS, V165, P1124, DOI 10.1093/infdis/165.6.1124
- Tsuboi M, 2021, LANCET GLOB HEALTH, V9, pE1110, DOI 10.1016/S2214-109X(21)00221-7
- Zetola NM, 2007, CLIN INFECT DIS, V44, P1222, DOI 10.1086/513427
- Zhang Y, 2022, SEX TRANSM INFECT, V98, P608, DOI 10.1136/sextrans-2022-055546